Entity Common Stock, Shares Outstanding of XTL BIOPHARMACEUTICALS LTD from 15 Mar 2018 to 31 Dec 2024

Taxonomy & unit: dei: shares
Description: Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary: XTL BIOPHARMACEUTICALS LTD quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 15 Mar 2018 to 31 Dec 2024.
XTL BIOPHARMACEUTICALS LTD Entity Common Stock, Shares Outstanding for the quarter ending 31 Dec 2024 was 881,385,176.
Source SEC data: View on sec.gov

Entity Common Stock, Shares Outstanding, Quarterly (shares)

Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

XTL BIOPHARMACEUTICALS LTD Quarterly Entity Common Stock, Shares Outstanding (shares)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2024	881,385,176			31 Dec 2024	20-F	30 Apr 2025	2024	FY
Q4 2022	544,906,149	0	0%	31 Dec 2022	20-F	22 Mar 2023	2022	FY
Q4 2021	544,906,149	+30,700,350	+6%	31 Dec 2021	20-F	30 Mar 2022	2021	FY
Q4 2020	514,205,799	0	0%	31 Dec 2020	20-F/A	19 May 2021	2020	FY
Q4 2019	514,205,799			31 Dec 2019	20-F	12 Mar 2020	2019	FY
Q1 2019	514,205,799	0	0%	10 Mar 2019	20-F	11 Mar 2019	2018	FY
Q1 2018	514,205,799			15 Mar 2018	20-F	15 Mar 2018	2017	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.